News
9d
Zacks Investment Research on MSNReasons to Add Fresenius Medical Stock to Your Portfolio NowFresenius Medical Care AG & Co. FMS is well-poised for growth on the back of strategic acquisitions and partnerships and a ...
Fresenius offers international diversification, stable healthcare exposure, and upside from a strategic pivot. Find out why ...
Sarah Schmidt is returning to K Street to join kidney dialysis company Fresenius Medical Care as a vice president and head of federal government relations.
8d
GlobalData on MSNFresenius Medical starts US commercialisation of haemodiafiltration systemFresenius Medical Care (FME) has commenced the US commercialisation of its high-volume haemodiafiltration (HVHDF) kidney ...
8d
TipRanks on MSNFresenius SE price target raised to EUR 52 from EUR 43 at CitiCiti raised the firm’s price target on Fresenius SE (FSNUY) to EUR 52 from EUR 43 and keeps a Buy rating on the shares. Published first on TheFly ...
Fresenius (FMS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...
Fresenius Medical Care treats end-stage renal disease, or ESRD, patients primarily through its dialysis clinic network and related medical technology. Its strengths in these related areas help ...
Aurora™ is the automated system that streamlines plasma collection, producing virtually cell-free plasma and providing an improved experience for both operators and donors. The system separates ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
In response to the proposal presented by Fresenius Medical Care, the Subject Expert Committee (SEC) functional under the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results